文献速递精神分裂症与精神病性障碍

线粒体生物发生与精神分裂症可变外显率的关联

Association of Mitochondrial Biogenesis With Variable Penetrance of Schizophrenia.
PubMed 文献 · JAMA Psychiatry · 2021-01-01

该病例对照研究比较了22q11.2缺失综合征(22q11DS)伴或不伴精神分裂症个体及正常对照的诱导多能干细胞衍生神经元和淋巴母细胞系,发现线粒体生物发生增强与22q11DS中精神分裂症缺失相关,且ATP缺陷可被促进线粒体生物发生的药物逆转。

要点

  • 22q11DS伴精神分裂症患者神经元ATP水平和OXPHOS活性降低。
  • 不伴精神分裂症的22q11DS个体线粒体生物发生基因表达上调。
  • 促进线粒体生物发生可纠正22q11DS伴精神分裂症神经元的ATP缺陷。

核心结论

  • 线粒体生物发生和功能增强与22q11DS个体不发生精神分裂症相关。
  • 22q11DS伴精神分裂症组的线粒体缺陷可被增强线粒体生物发生的药物逆转。

研究设计与样本

  • 病例对照研究,比较14个诱导多能干细胞衍生神经元系(对照组6系,22q11DS组8系,其中伴与不伴精神分裂症各4系)。
  • 另采用独立成人22q11DS淋巴母细胞系(伴精神分裂症10系,不伴8系)进行验证。
  • 数据于2019年7月1日至2021年1月24日分析。

主要发现

  • 不伴精神分裂症的22q11DS组线粒体生物发生基因(包括PGC1α)表达上调。

关键数值与推荐

  • 22q11DS不伴精神分裂症组神经元中多个编码OXPHOS亚基的基因表达显著上调。
  • 刺激线粒体生物发生可 normalize 22q11DS伴精神分裂症神经元的ATP缺陷。

临床怎么用

  • 增强线粒体生物发生可能成为22q11DS个体精神分裂症治疗或预防的可靶向策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Discovery of mechanisms that underlie variable penetrance for neuropsychiatric illness in the context of genetic variants that carry elevated risk can advance novel treatment approaches for these disorders. OBJECTIVE: To test the hypothesis that mitochondrial compensation is associated with the variable penetrance of schizophrenia in the 22q11.2 deletion syndrome (22q11DS). DESIGN, SETTING, AND PARTICIPANTS: This case-control study compared measures of mitochondrial function and the expression of related genes in 14 induced pluripotent stem cell-derived neurons from typically developing control individuals (6 lines) and from adults with 22q11DS (8 lines). The individuals with 22q11DS included 2 groups, those carrying a diagnosis of schizophrenia and those without this diagnosis (4 lines each). Similar measures were made of lymphoblastic cells lines (LCLs) from a separate group of adults with 22q11DS with (10 lines) or without (8 lines) schizophrenia. The study included samples derived from a clinical setting. The induced pluripotent stem cell lines were derived from individuals with 22q11DS with or without a diagnosis of schizophrenia at Stanford University. The LCLs were from adults within the 22q and You Center at the Children's Hospital of Philadelphia. Data were analyzed between July 1, 2019, and January 24, 2021. MAIN OUTCOMES AND MEASURES: Total adenosine triphosphate (ATP), oxidative phosphorylation (OXPHOS) complex activity, and messenger RNA expression via reverse transcription-polymerase chain reaction of selected genes encoding for mitochondrial proteins. RESULTS: Study participants included men and women aged 18 to 37 years. Of 32 participants, the mean (SD) age of men was 27 (1.9) years and of women was 29 (1.2) years. Replicating a previous study, neurons from the 22q11DS and schizophrenia (22q+Sz) group had reduced ATP levels (mean [SD], 15.6 [1.5] vs 21.9 [1.4]; P = .02) and reduced OXPHOS activity (ie, complex I; 1.51 [0.1] vs 1.89 [0.1]; P = .01). These deficits were not present in neurons from individuals with 22q11DS without schizophrenia (22q[-]Sz). In this group, the expression of multiple genes encoding OXPHOS subunits was significantly upregulated. For example, compared with control individuals, NDUFV2 expression was increased by 50% in the 22q(-)Sz group (P < .001) but not significantly changed in the 22q+Sz group. Expression of genes driving mitochondrial biogenesis, including PGC1α, showed a similar pattern of upregulation in the 22q(-)Sz group compared with the control and the 22q+Sz groups. Stimulation of mitochondrial biogenesis normalizes the ATP deficit seen in 22q+Sz neurons. Finally, using LCLs from a separate group of adults with 22q11DS, evidence for enhanced mitochondrial biogenesis was again found in the 22q(-)Sz group. CONCLUSIONS AND RELEVANCE: In this study, an increase in mitochondrial biogenesis and function was associated with the absence of schizophrenia in neurons and LCLs from individuals with 22q11DS, but the deficit in the 22q+Sz group was reversible by agents that enhance mitochondrial biogenesis. Enhancement of mitochondrial biogenesis may provide a targetable opportunity for treatment or prevention of this disorder in individuals with 22q11DS.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Li J, Tran OT, Crowley TB, et al. Association of Mitochondrial Biogenesis With Variable Penetrance of Schizophrenia. JAMA Psychiatry. 2021. PMID: 34009292. doi:10.1001/jamapsychiatry.2021.0762

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。